PRN: Brain Cancer Drugs Price Analysis and Strategies 2016-2021 - Research and Markets

23/feb/2017 21:00:26 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Brain Cancer Drugs Price Analysis and Strategies 2016-2021 - Research and Markets

 
[23-February-2017]
 


DUBLIN, Feb 23, 2017 /PRNewswire/ --


Research and Markets has announced the addition of the "Brain Cancer Drugs Price Analysis and Strategies - 2016" report to their offering.

The latest research Brain Cancer Drugs Price Analysis and Strategies - 2016, provides drug pricing data and benchmarks in the global Brain Cancer market.

The research answers the following questions:

  • What are the key drugs marketed for Brain Cancer and their clinical attributes? How are they positioned in the Global Brain Cancer market?
  • What are the unit prices and annual treatment cost for Brain Cancer therapies in different countries? What are the drug pricing trends and how are they expected to change in the future? How are the drug pricing and reimbursement landscape different by countries?
  • What are the unmet needs in the global Brain Cancer drugs market? What would be the ideal pricing strategy for a new pipeline therapy for Brain Cancer?

Research Scope:

  • Brain Cancer Treatment Options - Identify key drugs marketed and prescribed for Brain Cancer in the US, Germany, France, Italy, Spain, UK, Japan including trade name, molecule name, and company
  • Brain Cancer Drugs Attributes - Find out the safety, efficacy, and risk benefit for key drugs marketed for Brain Cancer
  • Market Positioning - Identify how drugs are clinically and commercially positioned in the global Brain Cancer market
  • Brain Cancer Drugs Price Analysis - Find out the annual therapy cost and unit price for key drugs marketed for Brain Cancer in the US, Germany, France, Italy, Spain, UK, Japan. Find out how the price advanced from 2012 and forecast to 2021
  • Pricing & Reimbursement Landscape - Find out the pricing and reimbursement landscape in the US, Germany, France, Italy, Spain, UK, Japan
  • Brain Cancer New Drug Pricing - Identify the effective pricing strategy for a new drug launch in the US, Germany, France, Italy, Spain, UK, Japan

This research will help executives

  • Identify clinical attributes of your competitor drugs
  • Find out how the marketed products for Brain Cancer are clinically and commercially positioned
  • Understand the price of your competitor drugs by countries
  • Use Brain Cancer drugs price data for market sizing, drug sales forecast, budgeting, competitive intelligence, HEOR, and reimbursement
  • Find out the pricing and reimbursement landscape by countries
  • Identify the unmet need in global Brain Cancer market
  • Identify the effective pricing for a new drug


Key Topics Covered:

1. Brain Cancer Treatment Options
2. Brain Cancer Drugs Clinical Attributes
3. Brain Cancer Drugs Market Positioning
4. Brain Cancer Drugs Price Analysis
4.1. Brain Cancer Drugs Price Analysis - US
4.2. Brain Cancer Drugs Price Analysis - Germany
4.3. Brain Cancer Drugs Price Analysis - France
4.4. Brain Cancer Drugs Price Analysis - Italy
4.5. Brain Cancer Drugs Price Analysis - Spain
4.6. Brain Cancer Drugs Price Analysis - UK
4.7. Brain Cancer Drugs Price Analysis - Japan
5. Brain Cancer Drugs Price Benchmarks
6. Drug Pricing & Reimbursement Landscape
6.1. Drug Pricing & Reimbursement Landscape - US
6.2. Drug Pricing & Reimbursement Landscape - Germany !
6.3. Drug Pricing & Reimbursement Landscape - France
6.4. Drug Pricing & Reimbursement Landscape - Italy
6.5. Drug Pricing & Reimbursement Landscape - Spain
6.6. Drug Pricing & Reimbursement Landscape - UK
6.7. Drug Pricing & Reimbursement Landscape - Japan
7. Brain Cancer Drugs Price Forecast
8. Brain Cancer Market Unmet Needs
9. Brain Cancer New Drug Pricing
10. Research Methodology

Table 1: Brain Cancer Marketed Drugs, Global, 2016
Table 2: Brain Cancer Drugs Clinical Attribute Analysis, Global, 2016
Table 3: Brain Cancer Drugs Unit Price, Global, 2012 - 2016
Table 4: Brain Cancer Drugs Annual Treatment Cost, Global, 2012 - 2016
Table 5: Brain Cancer Drugs Unit Price, US, 2012 - 2016
Table 6: Brain Cancer Drugs Annual Treatment Cost, US, 2012 ! - 2016
Table 7: Brain Cancer Drugs Unit Price, Germany, 2012 - 2016
Table 8: Brain Cancer Drugs Annual Treatment Cost, Germany, 2012 - 2016
Table 9: Brain Cancer Drugs Unit Price, France, 2012 - 2016
Table 10: Brain Cancer Drugs Annual Treatment Cost, France, 2012 - 2016
Table 11: Brain Cancer Drugs Unit Price, Italy, 2012 - 2016
Table 12: Brain Cancer Drugs Annual Treatment Cost, Italy, 2012 - 2016
Table 13: Brain Cancer Drugs Unit Price, Spain, 2012 - 2016
Table 14: Brain Cancer Drugs Annual Treatment Cost, Spain, 2012 - 2016
Table 15: Brain Cancer Drugs Unit Price, UK, 2012 - 2016
Table 16: Brain Cancer Drugs Annual Treatment Cost, UK, 2012 - 2016
Table 17: Brain Cancer Drugs Unit Price, Japan, ! 2012 - 2016
Table 18: Brain Cancer Drugs Annual Treatment Cost, Japan, 2012 - 2016
Table 19: Brain Cancer Drugs Price Comparison Benchmarks, Global, 2016
Table 20. Drug Pricing Landscape by Countries, 2016
Table 21: Drug Reimbursement Landscape by Countries, 2016
Table 22: Brain Cancer Drugs Price Forecast, Global, 2016 - 2021
Table 23: Brain Cancer Drugs Price Forecast, US, 2016 - 2021
Table 24: Brain Cancer Drugs Price Forecast, Germany, 2016 - 2021
Table 25: Brain Cancer Drugs Price Forecast, France, 2016 - 2021
Table 26: Brain Cancer Drugs Price Forecast, Italy, 2016 - 2021
Table 27: Brain Cancer Drugs Price Forecast, Spain, 2016 - 2021
Table 28: Brain Cancer Drugs Price Forecast, UK, 2016 - 2021
Table 29: Brain Cancer Drugs Price Forecast, Japan, 2016 - 2021
Table 30: Bra! in Cance r Market Unmet Needs
Table 31: Brain Cancer New Drugs Pricing, Global, 2016 - 2021

Figure 1: Brain Cancer Drugs Market Positioning, Global, 2016
Figure 2: Brain Cancer Drugs Unit Price, Global, 2012 - 2016
Figure 3: Brain Cancer Drugs Annual Treatment Cost, Global, 2012 - 2016
Figure 4: Brain Cancer Drugs Unit Price, US, 2012 - 2016
Figure 5: Brain Cancer Drugs Annual Treatment Cost, US, 2012 - 2016
Figure 6: Brain Cancer Drugs Unit Price, Germany, 2012 - 2016
Figure 7: Brain Cancer Drugs Annual Treatment Cost, Germany, 2012 - 2016
Figure 8: Brain Cancer Drugs Unit Price, France, 2012 - 2016
Figure 9: Brain Cancer Drugs Annual Treatment Cost, France, 2012 - 2016
Figure 10: Brain Cancer Drugs Unit Price, Italy, 2012 - 2016
Figure 11: Brain Cancer Dru! gs Annual Treatment Cost, Italy, 2012 - 2016
Figure 12: Brain Cancer Drugs Unit Price, Spain, 2012 - 2016
Figure 13: Brain Cancer Drugs Annual Treatment Cost, Spain, 2012 - 2016
Figure 14: Brain Cancer Drugs Unit Price, UK, 2012 - 2016
Figure 15: Brain Cancer Drugs Annual Treatment Cost, UK, 2012 - 2016
Figure 16: Brain Cancer Drugs Unit Price, Japan, 2012 - 2016
Figure 17: Brain Cancer Drugs Annual Treatment Cost, Japan, 2012 - 2016
Figure 18: Brain Cancer Drugs Price Comparison Benchmarks, Global, 2016
Figure 19: Brain Cancer Drugs Price Forecast, Global, 2016 - 2021
Figure 20: Brain Cancer Drugs Price Forecast, US, 2016 - 2021
Figure 21: Brain Cancer Drugs Price Forecast, Germany, 2016 - 2021
Figure 22: Brain Cancer Drugs ! Price Forecast, France, 2016 ! - 2021 < br/>Figure 23: Brain Cancer Drugs Price Forecast, Italy, 2016 - 2021
Figure 24: Brain Cancer Drugs Price Forecast, Spain, 2016 - 2021
Figure 25: Brain Cancer Drugs Price Forecast, UK, 2016 - 2021
Figure 26: Brain Cancer Drugs Price Forecast, Japan, 2016 - 2021
Figure 27: Brain Cancer New Drugs Pricing, Global, 2016 - 2021

For more information about this report visit http://www.researchandmarkets.com/research/kkx8wk/brain_cancer

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716



blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl